We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+19.78%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$45.9B
AUM Growth
+$5.92B
(+15%)
Cap. Flow
-$190M
Cap. Flow
% of AUM
-0.41%
Top 10 Holdings %
Top 10 Hldgs %
24.37%
Holding
916
New
168
Increased
229
Reduced
363
Closed
115
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$338M |
| 2 |
ExxonMobil
XOM
|
+$291M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$271M |
| 4 |
GE Aerospace
GE
|
+$205M |
| 5 |
Emerson Electric
EMR
|
+$157M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$310M |
| 2 |
Sensata Technologies
ST
|
+$251M |
| 3 |
Fortive
FTV
|
+$226M |
| 4 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
+$117M |
| 5 |
Honeywell
HON
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.79% |
| 2 | Healthcare | 18.35% |
| 3 | Consumer Discretionary | 12.96% |
| 4 | Financials | 12.38% |
| 5 | Communication Services | 8.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Albemarle
ALB
$15.2B
| $17.4M | 0.04% |
117,979
+47,500
| +67% | +$5.64M |
|
|
CHMA
452
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $17.4M | 0.04% |
4,000,000
-900,000
| -18% | -$3.75M |
|
|
VAR
453
DELISTED
Varian Medical Systems, Inc.
VAR
| $17.4M | 0.04% |
99,359
-2,740
| -3% | -$475K |
|
454
UDR
UDR
$12.3B
| $17.4M | 0.04% |
452,358
+135,258
| +43% | +$4.93M |
|
|
CVET
455
DELISTED
Covetrus, Inc. Common Stock
CVET
| $17.2M | 0.04% |
600,000
-140,000
| -19% | -$3.78M |
|
456
Nucor
NUE
$61.8B
| $17.2M | 0.04% |
323,535
-12,900
| -4% | -$666K |
|
457
EQT Corp
EQT
$32.4B
| $17.2M | 0.04% |
+1,350,000
| New | +$19.4M |
|
|
HOLX
458
DELISTED
Hologic
HOLX
| $17.2M | 0.04% |
235,586
-204,390
| -46% | -$14.4M |
|
459
Cardinal Health
CAH
$56B
| $17.1M | 0.04% |
320,100
+1,500
| +0.5% | +$77.8K |
|
|
RWT
460
Redwood Trust
RWT
$593M
| $17.1M | 0.04% |
1,949,275
+400,790
| +26% | +$3.45M |
|
461
Waters Corp
WAT
$39.3B
| $17.1M | 0.04% |
69,108
-235
| -0.3% | -$53.2K |
|
462
Airbnb
ABNB
$104B
| $16.9M | 0.04% |
+115,000
| New | +$17M |
|
463
W.W. Grainger
GWW
$60.6B
| $16.9M | 0.04% |
41,271
+1,900
| +5% | +$747K |
|
464
Pentair
PNR
$11.2B
| $16.8M | 0.04% |
+317,294
| New | +$16.3M |
|
465
Nasdaq
NDAQ
$53.3B
| $16.8M | 0.04% |
380,040
+900
| +0.2% | +$38.1K |
|
466
Teleflex
TFX
$6B
| $16.8M | 0.04% |
40,705
-61,416
| -60% | -$22.7M |
|
467
Essex Property Trust
ESS
$18.5B
| $16.6M | 0.04% |
70,000
-2,800
| -4% | -$646K |
|
468
Pool Corp
POOL
$7.51B
| $16.5M | 0.04% |
44,400
+6,857
| +18% | +$2.39M |
|
469
Darden Restaurants
DRI
$24.4B
| $16.5M | 0.04% |
138,800
-5,400
| -4% | -$578K |
|
|
CTLT
470
DELISTED
CATALENT, INC.
CTLT
| $16.3M | 0.04% |
156,700
+800
| +0.5% | +$77.5K |
|
471
West Pharmaceutical
WST
$25B
| $16.2M | 0.04% |
57,307
-25,250
| -31% | -$7.09M |
|
472
Extra Space Storage
EXR
$31.7B
| $16.2M | 0.04% |
140,000
-5,300
| -4% | -$604K |
|
473
StepStone Group
STEP
$4.01B
| $16.1M | 0.04% |
404,451
-131,971
| -25% | -$3.82M |
|
474
Teledyne Technologies
TDY
$31.7B
| $16M | 0.04% |
40,913
-887
| -2% | -$318K |
|
475
Cencora
COR
$61.7B
| $16M | 0.03% |
163,600
+1,000
| +0.6% | +$100K |
|
Similar funds
Adage Capital Partners's Q4 2020 Portfolio in Review
As of Q4 2020, Adage Capital Partners held 916 positions worth $45.9B, up 15% from $39.9B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Adage Capital Partners's Q4 2020 filing shows 168 new, 229 increased, 363 reduced and 115 closed positions. Its largest new stake was Tesla: 1,978,500 shares worth $465M. The largest sale was Royalty Pharma, an estimated $310M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Adage Capital Partners's largest Q4 2020 buy was Tesla: 1,978,500 shares worth $465M.
- Adage Capital Partners added most to ExxonMobil in Q4 2020, an estimated $291M increase.
- Adage Capital Partners's biggest Q4 2020 reduction was Royalty Pharma, cutting an estimated $310M.
- Adage Capital Partners fully exited Sensata Technologies in Q4 2020, selling an estimated $251M.
- Adage Capital Partners's ten largest holdings make up 24% of its $45.9B portfolio in Q4 2020.
- Adage Capital Partners opened 168 new positions and closed 115 in Q4 2020.
- Adage Capital Partners's portfolio value rose 15% quarter-over-quarter to $45.9B.
Based on Adage Capital Partners's 13F filing for Q4 2020, filed 16 Feb 2021.